EVEN BETTER MAKEUP BROAD SPECTRUM SPF 15- octinoxate, titanium dioxide, and zinc oxide liquid 
CLINIQUE LABORATORIES LLC

----------

EVEN BETTER MAKEUP

BROAD SPECTRUM SPF 15

Drug Facts

Active ingredients

Octinoxate 5.9%
Titanium Dioxide 3.5%
Zinc Oxide 2.8%

Purpose

Sunscreen

Use

helps prevent sunburn

Warnings

For external use only

Do not use on damaged or broken skin

When using this product keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if rash occurs

Keep out of reach of children.

If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

For sunscreen use:

Inactive ingredients

water\aqua\eau • methyl trimethicone • phenyl trimethicone • dimethicone • triethylhexanoin • butylene glycol • trimethylsiloxysilicate • yeast extract\faex\extrait de levure • peg-10 dimethicone • lauryl peg-9 polydimethylsiloxyethyl dimethicone • alumina • citrus grandis (grapefruit) peel extract • betula alba (birch) bark extract • saccharomyces lysate extract • astrocaryum murumuru seed butter • c12-15 alkyl benzoate • glycerin • sodium myristoyl sarcosinate • acetyl glucosamine • caprylyl methicone • methicone • polyglyceryl-6 polyricinoleate • disteardimonium hectorite • dimethicone crosspolymer-3 • isopropyl titanium triisostearate • lecithin • laureth-7 • tocopheryl acetate • magnesium ascorbyl phosphate • dimethicone/peg-10/15 crosspolymer • dipropylene glycol • sodium chloride • caprylyl glycol • tetrahexyldecyl ascorbate • disodium edta • phenoxyethanol • polyaminopropyl biguanide • [+/- titanium dioxide (ci 77891) • iron oxides (ci 77491, ci 77492, ci 77499) • mica • bismuth oxychloride (ci 77163)] [iln39834]

Other information

protect the product in this container from excessive heat and direct sun

DIST.
NEW YORK, N.Y. 10022

PRINCIPAL DISPLAY PANEL - 30 ml Bottle Carton

Principal Display PanelC

CLINIQUE

even better

makeup

broad spectrum

SPF 15

evens and corrects

1 FL.OZ.LIQ./30 ml e

EVEN BETTER MAKEUP  BROAD SPECTRUM SPF 15
octinoxate, titanium dioxide, and zinc oxide liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49527-025
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE59 mg  in 1 mL
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE35 mg  in 1 mL
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE28 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
METHYL TRIMETHICONE (UNII: S73ZQI0GXM)  
PHENYL TRIMETHICONE (UNII: DR0K5NOJ4R)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
YEAST, UNSPECIFIED (UNII: 3NY3SM6B8U)  
ALUMINUM OXIDE (UNII: LMI26O6933)  
CITRUS MAXIMA FRUIT RIND (UNII: 5NX3G75CA6)  
BETULA PUBESCENS BARK (UNII: 3R504894L9)  
SACCHAROMYCES LYSATE (UNII: R85W246Z1C)  
ASTROCARYUM MURUMURU SEED BUTTER (UNII: 12V64UPU6R)  
ALKYL (C12-15) BENZOATE (UNII: A9EJ3J61HQ)  
GLYCERIN (UNII: PDC6A3C0OX)  
SODIUM MYRISTOYL SARCOSINATE (UNII: J07237209D)  
N-ACETYLGLUCOSAMINE (UNII: V956696549)  
CAPRYLYL TRISILOXANE (UNII: Q95M2P1KJL)  
ISOPROPYL TITANIUM TRIISOSTEARATE (UNII: 949E3KBJ1I)  
LAURETH-7 (UNII: Z95S6G8201)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
MAGNESIUM ASCORBYL PHOSPHATE (UNII: 0R822556M5)  
DIPROPYLENE GLYCOL (UNII: E107L85C40)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
TETRAHEXYLDECYL ASCORBATE (UNII: 9LBV3F07AZ)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
POLIHEXANIDE (UNII: 322U039GMF)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
MICA (UNII: V8A1AW0880)  
BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:49527-025-011 in 1 CARTON09/01/2012
130 mL in 1 BOTTLE; Type 0: Not a Combination Product
2NDC:49527-025-021 mL in 1 PACKET; Type 0: Not a Combination Product01/04/202212/31/2023
3NDC:49527-025-031.5 mL in 1 PACKET; Type 0: Not a Combination Product01/04/202212/31/2023
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02009/01/2012
Labeler - CLINIQUE LABORATORIES LLC (044475127)
Registrant - Estee Lauder Companies Inc. (790802086)
Establishment
NameAddressID/FEIBusiness Operations
Estee Lauder Cosmetics Ltd.202952982manufacture(49527-025)
Establishment
NameAddressID/FEIBusiness Operations
Estee Lauder Cosmetics Ltd.204132062pack(49527-025) , label(49527-025) , manufacture(49527-025)
Establishment
NameAddressID/FEIBusiness Operations
Estee Lauder N.V.370151326manufacture(49527-025) , pack(49527-025) , label(49527-025)

Revised: 1/2024
Document Id: 0e87fa56-f2c2-f99b-e063-6294a90a94da
Set id: d4de3c7b-3993-40e5-88a4-f6005ab97531
Version: 14
Effective Time: 20240109
 
CLINIQUE LABORATORIES LLC